Antiepileptic Drugs Market By Drug Type (First-Generation AEDs {Phenobarbital, Phenytoin, Carbamazepine, Valproate}, Second-Generation AEDs {Lamotrigine, Levetiracetam, Topiramate, Oxcarbazepine, Zonisamide}, Third-Generation AEDs {Lacosamide, Eslicarbazepine Acetate, Perampanel}), By Route Of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Drug Type

• First-generation AEDs
  • Phenobarbital
  • Phenytoin
  • Carbamazepine
  • Valproate
• Second-generation AEDs
  • Lamotrigine
  • Levetiracetam
  • Topiramate
  • Oxcarbazepine
  • Zonisamide
• Third-generation AEDs
  • Lacosamide
  • Eslicarbazepine acetate
  • Perampanel

By Route of Administration

• Oral
• Intravenous

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Pfizer Inc.
• GlaxoSmithKline plc
• UCB Pharma S.A.
• Eisai Co., Ltd.
• Novartis International AG
• Sanofi S.A.
• AbbVie Inc.
• Johnson & Johnson
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Lupin Limited
• Zogenix, Inc.
• Bausch Health Companies Inc.
• Amneal Pharmaceuticals LLC
• Aurobindo Pharma Limited